Any sex offender convicted and sentenced under Penal Code section 645 shall begin medroxyprogesterone acetate (or its chemical equivalent) treatment one week prior to release from confinement in the state prison or other institution and shall continue treatments until the Department demonstrates to the Board that treatment is no longer necessary.
(a) If the Department determines that the parolee's medical condition requires the termination of the treatment, the Department will immediately transmit a written notification from a medical doctor so stating to the Chairman or the Executive Officer of the Board. The Chairman or the Executive Officer shall issue a temporary order to discontinue the treatment pending a parole revocation hearing.(b) If the Department determines that treatment is no longer necessary, the Department shall send written notification to the Board. The Board will thereafter hold a hearing before a commissioner or deputy commissioner to determine whether the Department has demonstrated that treatment is no longer necessary.Cal. Code Regs. Tit. 15, § 2513.2
1. New section filed 10-13-98; operative 11-12-98 (Register 98, No. 42). Note: Authority cited: Sections 3052 and 5076.1, Penal Code. Reference: Section 645, Penal Code.
1. New section filed 10-13-98; operative 11-12-98 (Register 98, No. 42).